Register for email alerts and news feeds:
This journal | BMJ Group
rss
Journal of Medical Ethics 2007;33:514-518; doi:10.1136/jme.2006.017723
Copyright © 2007 by the BMJ Publishing Group Ltd & Institute of Medical Ethics.

CLINICAL ETHICS

Views of patients with heart failure about their role in the decision to start implantable cardioverter–defibrillator treatment: prescription rather than participation

Anders Ågård1, Rurik Löfmark2, Nils Edvardsson3 and Inger Ekman4

1 Department of Medical Ethics, Lund University, Lund; Department of Medicine, Sahlgrenska University Hospital Göteborg, Sweden
2 Centre for Bioethics at the Karolinska Institutet; Uppsala University, Solna, Sweden
3 Division of Cardiology, Sahlgrenska University Hospital, Göteborg, Sweden
4 The Sahlgrenska Academy, Faculty of Health and Caring Sciences, Institute of Nursing, Göteborg University, Sweden

Correspondence to:
Correspondence to:
Dr A S Ågård
Department of Medicine, Sahlgrenska University Hospital/Sahlgrenska Hospital, Göteborg 41345, Sweden; anders.s.agard{at}vgregion.se

Background: There is a shortage of reports on what potential recipients of implantable cardioverter–defibrillators (ICDs) need to be informed about and what role they can and want to play in the decision-making process when it comes to whether or not to implant an ICD.

Aims: To explore how patients with heart failure and previous episodes of malignant arrhythmia experience and view their role in the decision to initiate ICD treatment.

Patients and methods: A qualitative content analysis of semistructured interviews was used. The study population consisted of 31 outpatients with moderate heart failure at the time of their first ICD implantation.

Setting: The study was performed at Sahlgrenska University Hospital, Göteborg, Sweden.

Results: None of the respondents had discussed the alternative option of receiving treatment with anti-arrhythmic drugs, the estimated risk of a fatal arrhythmia, or the expected time of survival from heart failure in itself. Even so, very little criticism was directed at the lack of information or the lack of participation in the decision-making process. The respondents felt that they had to rely on the doctors’ recommendation when it comes to such a complex and important decision. None of them regretted implantation of the ICD.

Conclusions: The respondents were confronted by a matter of fact. They needed an ICD and were given an offer they could not refuse, simply because life was precious to them. Being able to give well-informed consent seemed to be a matter of less importance for them.

Abbreviations: ICD, implantable cardioverter–defibrillator


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Article

The ethics of implantable devices
Eugene B Wu
J. Med. Ethics 2007 33: 532-533. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

  • Wu, E. B (2007). The ethics of implantable devices. J. Med. Ethics 33: 532-533 [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.